Jon Smythe

1.2k citations
25 papers · 752 indexed · h-index 15
Topics
Angiogenesis and VEGF in Cancer (5 papers)Mesenchymal stem cell research (4 papers)Blood groups and transfusion (3 papers)

In The Last Decade

Jon Smythe

24 papers receiving 739 citations

Peers

Jon Smythe
Comparison fields: 5 of 87
  • Molecular Biology 329
  • Oncology 178
  • Cancer Research 133
  • Genetics 120
  • Pulmonary and Respiratory Medicine 89
Replace Laura M. Rosenberg with:
Laura M. Rosenberg United States
Jacqueline Ming Liu Taiwan
Hiroyuki Eda Japan
Miao-Fen Chen Taiwan
Renata Binato Brazil
Ningning He China
Hong‐Wei Gao Taiwan
Jawad A. Makarem Lebanon
Paz de la Torre Spain
Ida Katrine Lund Denmark
Jon Smythe relative to Laura M. Rosenberg United States Laura M. Rosenberg's profile →
Citations per field
00.5×1.5×2.2×
Laura M. Rosenberg · 1×
Citations per year

Countries citing papers authored by Jon Smythe

Since Specialization
Citations

This map shows the geographic impact of Jon Smythe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Smythe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Smythe more than expected).

Fields of papers citing papers by Jon Smythe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Smythe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Smythe. The network helps show where Jon Smythe may publish in the future.

Co-authorship network of co-authors of Jon Smythe

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Smythe. A scholar is included among the top collaborators of Jon Smythe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Smythe. Jon Smythe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 73
3 6
4 153
5 1
6 16
7 64
8 35
9 27
10 21
11 82
12 15
13 68
14 26
15 14
16 3
17 23
18 6
19 1
20
Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis.
12

About Jon Smythe

Jon Smythe is a scholar working on Medical Laboratory Technology, Hematology and Genetics, having authored 25 papers that have together received 752 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (5 papers), Mesenchymal stem cell research (4 papers) and Blood groups and transfusion (3 papers). The work is most often cited by research in Genetics (120 citations), Cancer Research (133 citations) and Oncology (178 citations). Jon Smythe has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Adrian L. Harris, Suzanne M. Watt, Nita Fisher, Paul Nathan, Ian Judson, Michael Tyler, Gordon Rustin, David J. Collins, Martin Zweifel and Dow‐Mu Koh. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026